Thorne HealthTech, Inc. (THRN) Tops Q2 EPS by 9c

August 8, 2023 4:39 PM EDT

Thorne HealthTech, Inc. (NASDAQ: THRN) reported Q2 EPS of $0.15, $0.09 better than the analyst estimate of $0.06. Revenue for the quarter came in at $72.7 million versus the consensus estimate of $68.41 million.

GUIDANCE:

Thorne HealthTech, Inc. sees FY2023 EPS of $0.26-$0.32, versus the consensus of $0.29. Thorne HealthTech, Inc. sees FY2023 revenue of $285-290 million, versus the consensus of $282 million.

For earnings history and earnings-related data on Thorne HealthTech, Inc. (THRN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings